JUNE 2019 | EYEWORLD | 29
O
From The Voice of
Ophthalmology
Tal Raviv, MD, New York, with coach Iqbal
"Ike" Ahmed, MD, Toronto, Canada, was
voted the winner of the second season of The
Voice of Ophthalmology for his presentation on
endophthalmitis prophylaxis with intracameral
antibiotics.
Major points from Dr. Raviv's presentation
included:
• Several studies showed no additive effect of
topical antibiotics after intracameral antibi-
otics were used, and a 2016 AAO Preferred
Practice Pattern supports the role of intraca-
meral antibiotics.
• With low adoption of intracameral antibi-
otics among U.S. surgeons, concern could
stem from there not being an FDA-approved
product and the association of intracameral
vancomycin with HORV.
• Compounding pharmacies and the commer-
cially available topical formulation of
moxifloxacin are options for intracameral
antibiotics.
From the Charles D. Kelman
Innovator's Lecture
Collaborative innovation can happen between technologies
where a particular technology can reach a certain level of
adoption, then additional technologies further it, according to
Ron Kurtz, MD.
Dr. Kurtz described moving femtosecond laser technol-
ogy into the realm of refractive cataract surgery. Refractive
cataract surgery really began in the 1960s, driven by the
large pool of patients who, thanks to Medicare, would
not have had access to these innovations otherwise. Inno-
vations included the first implantable IOLs, followed by
phaco, viscoelastic, keratometry, biometry, and IOL power
calculation formulas.
Dr. Kurtz shared his efforts on the Light Adjustable
Lens (RxSight). "I was intrigued by the ability to have an of-
fice-based system that could optimize patient vision after the
cataract had been removed," he said.
